Background. Chagas disease is caused by the protozoan parasite Trypanosoma cruzi, which exhibits a high genetic variability. TcI, TcII, or mixed TcI/TcII strains may be found during acute human infection while mainly TcII parasites are present at the chronic stage of disease. In a previously studied Chagas disease outbreak, we identified mixed TcI/TcII strains in the vector Triatoma tibiamaculata and only TcII strains in infected humans, indicating that T. cruzi populations may be selected within the human host.
Trypanosoma cruzi infects approximately 12 million people in Latin America, resulting in an incidence of 21 000 deaths [1] . About 30% of the patients during the indeterminate phase progress to the cardiac or digestive stage of the disease annually [2] . Despite the positive impact of the Southern Cone Initiative on Triatoma infestans control, it is estimated that around 70 million people remain living in transmission risk areas.
The mechanisms determining the clinical forms of Chagas disease have not been completely elucidated, but it is accepted that both host and parasite factors are involved [3] . Nevertheless, a number of reports have demonstrated that parasite variability plays a central role in Chagas disease [3] [4] [5] . Genetic variability data divide T. cruzi strains into 2 major phylogenetic lineages named TcI and TcII [6] . TcII lineage has been further divided into 5 groups, TcII through TcVI [7] . With a few exceptions, in South American countries including Brazil, TcI and TcII groups basically correspond to parasite strains associated with sylvatic and domestic transmission cycles, respectively [6] . Indeed, immunological evidence suggests that TcII strains are present in South American chronically infected subjects [8] , which was later confirmed in 25 Brazilian chronic chagasic patients [9] . Despite the presence of TcI/TcII populations in naturally infected vectors and reservoirs, only TcII strains, at least in Brazil, have been consistently observed in chronic chagasic patients [8] [9] [10] . Together, these data raise the hypothesis that TcII strains are selected in vivo during human infection.
The natural transmission of T. cruzi to humans occurs when infected triatomine bug feces/urine are inoculated in damaged skin or mucous during the blood meal [1, 2] . Host cell entry by T. cruzi is a multistep process involving a variety of molecules, which mobilize intracellular Ca 21 in both parasite and target cells [11] [12] [13] [14] . Metacyclic trypomastigotes express surface glycoproteins such as gp82, which is a Ca 21 signal-inducing molecule involved in cell adhesion/entry processes and may be T. cruzi strain-dependent [13, 14] . Additionally, following the initial parasite-cell interactions, diverse host immune system-associated cells and molecules are activated and may be differentially regulated by T. cruzi strains. During infection, T. cruzi interacts with host innate immune system components such as phagocytes [15] [16] [17] . While T. cruzi displays several mechanisms to escape immunological responses, the innate immune response controls parasite proliferation at early infection as well as regulates adaptive immune responses [16] [17] [18] [19] . Macrophages are thought to be a major cell population involved in parasite uptake. These cells can be activated by interferon gamma (IFN-c) and produce several intracellular killing mediators including nitric oxide (NO) [19, 20] . Although macrophages and other components of the immune system have been demonstrated to control parasite replication in vivo, it is not known whether macrophages are involved in T. cruzi selection. Despite the robust cellular and humoral immune responses, a small number of parasites may persist in the host, causing disease. The parasite's ability to survive to the acute phase and progress to the chronic stage appears to be dependent on both parasite variability and immune system pathways [3, 17] .
Molecular analysis of T. cruzi strains from an outbreak of acute Chagas disease in Santa Catarina, southern Brazil, identified mixed TcI/TcII patterns in strains derived from Triatoma tibiamaculata, while strains isolated from patients displayed the TcII pattern [21] . In the present study, utilizing vector-derived mixed TcI/TcII infective trypomastigotes, we have demonstrated that TcII but not TcI strains are selected by both murine and human macrophages. These findings suggest the existence of an intracellular mechanism that favors proliferation of TcII strains and could explain the observed in vivo parasite selection.
METHODS

Parasites
T. cruzi strains (SC90-SC102) have been described elsewhere [21] . Standard TcI, TcII, and Trypanosoma rangeli strains were used as controls in all experiments (Table 1) . Epimastigotes were grown in liver infusion tryptose (LIT) medium supplemented with 10% fetal bovine serum (FBS) at 26°C.
Macrophage Populations
Murine bone marrow-derived macrophages (BMMs) and human monocyte-derived macrophages were generated as previously described [22, 23] , respectively.
DNA Extraction and Polymerase Chain Reaction Assays
Epimastigote and trypomastigote DNA was extracted by the standard phenol-chloroform method; concentration/purity was determined by spectrophotometry, and DNA was stored at 220°C. Intraspecific variability of the T. cruzi strains was evaluated by random amplification polymorphic DNA (RAPD) using primers 3303/3304/3306/3307 [24] and AB1/AB5 [25] . Variability of the mini-exon, 24Sa ribosomal DNA (rDNA), and 18S rDNA genes was performed by polymerase chain reaction (PCR) amplification using primers Tc/Tc1/Tc2, D71/D72, and V1/V2, respectively (Table 1) as described elsewhere [26] .
Infection of Murine Bone Marrow-Derived Macrophages
BMMs were infected with LIT-derived trypomastigotes (1:1 parasite/cell) for 4 hours. Cells were then washed, cultured in the presence of fresh Dulbecco's modified Eagle's medium (DMEM) with 10% FBS in indicated time points, fixed with methanol, and Giemsa-stained. Infected cells and intracellular parasites were determined by random counting of 200 cells per slide (403) in a microscope (Olympus IX70). In some experiments, trypomastigotes were preincubated for 1 hour at 37°C with 50% heat-inactivated sera from either acute chagasic patients or healthy subjects (diluted in serum-free DMEM).
Parasite duplication time in BMMs was determined using the formula dt5
where dt 5 doubling time; t 1 5 72 hours; t 0 5 24 hours; N 1 5 mean number of parasites per infected cell at 72 hours of infection; and N 0 5 at 24 hours of infection. In a set of experiments, T. cruzi-infected BMMs were treated with recombinant IFN-c for 4 hours. Cells were then washed, incubated with additional IFN-c in indicated time points, methanol-fixed, and Giemsa-stained. Nitrite was measured in culture supernatants by the Griess method [27] using a colorimetric assay kit (Sigma-Aldrich).
Genotypic Characterization of TcI/TcII Following Passage in Murine Macrophages
BMMs were infected with SC92, SC93 (TcI/TcII naturally mixed strains), or SC90 plus SC96 (artificially prepared mixed strain). Following completion of the biological cycle, trypomastigotes were collected from culture supernatant and the proportion of TcI and TcII parasites was determined by previously standardized semiquantitative PCR using primers Tc1/Tc2/Tc3/TR/ME (Table 1 ; available online). PCR products in polyacrylamide gel were stained with ethidium bromide and images were recorded using Scion Image software, version 4.03 (Scion Corp).
Genotypic Characterization of TcI/TcII Following Serial Passages in Human Macrophages
Human monocyte-derived macrophages were infected with LITderived diethylaminoethyl cellulose-purified [28] trypomastigotes (ratio 5:1) of the SC92 strain. After 4 hours, nonadhered parasites were washed out and cells incubated with RPMI plus 5% FBS. Following 96 hours incubation (biological cycle completed), parasites were collected from supernatant and used to infect another plate of macrophages. This procedure was repeated 3 times (3 serial passages). After each passage, trypomastigotes collected from supernatant were submitted to DNA extraction and the TcI/TcII DNA proportion was estimated by qPCR as described elsewhere [9] with modifications. Reactions were performed with SYBR Green PCR Master Mix (Applied Biosystems) containing 100 pg DNA and 10 mM D71/D72 primers (Table 1 ; available online) and read in a StepOne Real-Time PCR System (Applied Biosystems) using the absolute quantification option. The thermocycling conditions were 50°C for 2 minutes and 95°C for 10 minutes, followed by 40 cycles at 95°C for 30 seconds, 60°C for 30 seconds, and 72°C for 1 minute. PCR products were slowly warmed from 60 to 95°C and the rDNA amplicon melting point was determined using the dissociation curve tool. Estimated proportions of TcI/TcII strains were performed by analysis of fluorescence values of each amplicon.
Measurement of gp82 Expression
Western blotting was carried out as described elsewhere [29] . In brief, T. cruzi protein extract (30 lg) was loaded in a 10% sodium dodecyl sulfate polyacrylamide gel, blotted onto a nitrocellulose membrane, and probed with monoclonal antibodies against gp82 (3F6, 1:200) or a-tubulin (1:500). Reactions were developed using ECL Plus (Amersham).
Experimental Infection With TcI and TcII Strains
Five-week-old male Balb/c mice were intraperitoneally infected with 10 5 cultured trypomastigotes (SC90 plus SC96). Blood samples were collected on days 7 and 14 after infection. In a set of experiments, at 1 hour and days 3, 7, and 14 after infection, peritoneal cells were collected by the injection of cold saline in the peritoneal cavity (10 mL/mouse). Percentage of infection by peritoneal cavity cells (PECs) was found to be 24.4%, 20.8%, 13.5%, and 9.9% at 1 hours, day 3, day 7, and day 14, respectively. Whole blood and PEC pellets were submitted to DNA extraction and the proportion of TcI/TcII parasites was determined by semiquantitative PCR as described above.
Statistical Analysis
Data are shown as means 6 SD of 2 or 3 experiments performed at least in triplicate. Groups were compared by the Tukey test for repeated measures, using Graph Prism InStat software, version 3.0. Differences were considered statistically significant at P , .05.
RESULTS
TcIIb T. cruzi Populations Are Maintained in Acutely Infected Humans Following an Oral Exposure Outbreak
During a recent Chagas disease outbreak due to oral transmission [21] , we isolated 2 parasite strains from vector T. tibiamaculata (TcI/TcII), 2 strains from reservoir Didelphis sp (TcI), and 9 strains from acutely diseased patients (TcII). To investigate the genetic relationship among all 13 strains at the molecular level, isolated parasites were analyzed by RAPD using 6 primers (Table 1 ). Figure 1A shows that strains isolated from Didelphis sp (SC90 and SC91) displayed identical molecular patterns, indicating low genetic variability. The naturally mixed strains obtained from triatomines (SC92 and SC93) presented a mixed (TcI/TcII) molecular profile. However, strains isolated from 9 patients (SC94-SC102) exhibited a complex electrophoretic profile but with low genetic variability. Furthermore, cluster analysis of wildtype and laboratory control T. cruzi strains revealed 4 main groups. Compared with the TcII reference strain Y T. cruzi, parasites isolated from patients (SC94-SC102) cluster into group B ( Figure 1B ). In contrast, cluster C grouped SC90 and SC91 TcI strains as well as SC92 and SC93 mixed TcI/TcII parasites, suggesting that these strains share similar genetic niches. Both clusters A (T. rangeli) and D (SC28 and Colombiana T. cruzi) were used as known strain references ( Figure 1B ). To determine the phylogenetic lineages (TcI, TcII, TcIII, TcIV, TcV, or TcVI) of T. cruzi strains isolated from patients, we performed a more detailed genotyping analysis employing 3 independent known markers: the mini-exon, 24Sa rDNA, and 18S rDNA [26] . All of the analyzed parasite strains displayed bands that correspond to 250 base pairs (bp) in the mini-exon, 125 bp in the 24Sa rDNA, and 165 bp in the 18S rDNA, therefore characterizing them into the TcIIb profile, currently denominated as TcII [7] . Together, these results confirm that T. cruzi strains isolated from vectors and reservoirs cluster into TcI and mixed TcI/TcII populations, respectively. Moreover, TcIIb T. cruzi parasites were found in acutely infected patients, suggesting that this pathogen has been selected in the human host. Consistent with this hypothesis, an animal model of T. cruzi infection in which mice were exposed intraperitoneally to a mixture of SC90 and SC96 (TcI/TcII) strains demonstrated that blood-circulating parasites display a genetic profile of TcII, but not TcI, on days 7 and 14 after infection (Figure 2A , lanes 7 and 8). In addition, PECs obtained from infected mice were found to present mixed TcI/TcII at 1 hour and 3 days after infection (Figure 2A, lanes 3 and 4) . More importantly, at days 7 and 14, PECs showed only TcII-associated genetic patterns (Figure 2A , lanes 5 and 6), suggesting that phagocytic cells in the peritoneal cavity ( Figure 2B ) participate in TcII parasite selection during in vivo infection. To investigate the role of macrophages in TcII selection, we next utilized an in vitro model in which primary cells were exposed to naturally obtained (SC92 or SC93) or artificially prepared (SC90 plus SC96) mixed strains. Following infection of macrophages and conclusion of the parasite biological cycle, cell-free trypomastigotes in the supernatants were collected and semiquantitative analysis of TcI/TcII was performed. Figure 2C shows that, compared with TcI/TcII before infection (lanes 3-5), trypomastigotes following macrophage passage displayed decreased amounts of DNA associated with TcI T. cruzi strains (lanes 6-8), suggesting that TcII strains are maintained following parasite-macrophage interactions. To study whether TcIassociated genotypic patterns decreased over time, experiments utilizing primary human macrophages were performed using quantitative analysis [9] . Monocyte-derived human macrophages were exposed to purified LIT-derived trypomastigotes of SC92 (natural TcI/TcII strain). Following completion of the biological cycle (1st passage), supernatant trypomastigotes were collected and utilized to infect a different set of macrophages (2nd passage), and so on. Figure 2D shows that the initial population rates of TcI and TcII in SC92 strain were found to be 77.4% and 22.6%, respectively. Increased TcII-and decreased TcI-associated markers were observed within serial passages in human macrophages (Figure 2, D and E) . Following the 3rd passage, the rate was 93.19% of TcII and 6.81% of TcI. These findings suggest that macrophages select TcII T. cruzi in vitro.
TcII Strains Display Higher Infective and Multiplicative Ability in Macrophages
Following T. cruzi inoculation into the human host, several innate immunity factors may take place [17, 18] . Despite the known trypomastigote resistance to complement system [15, 30, 31] , we studied whether complement plays a role in initial TcI vs TcII parasite selection. TcI (SC90), TcII (SC94 and Y), and TcI/ TcII (SC92 and SC93) trypomastigotes were found to be resistant to complement (data not shown), confirming that complement system is not involved in the selection of T. cruzi populations. We next investigated possible cellular factors involved in the selection of T. cruzi populations by first evaluating whether TcI, TcII, or mixed TcI/TcII strains display differences in macrophage-parasite interactions. Compared with TcI, TcII strains displayed higher infection rates, while mixed TcI/TcII strains presented intermediate infection rates (Figure 3A) . Similarly, TcII strains displayed increased multiplicative ability ( Figure 3B ) as well as a diminished intracellular doubling time ( Figure 3C ). In contrast, TcI strains presented a low multiplicative ability, which was associated with lower expression of gp82 ( Figure 3, D and E) , an important glycoprotein involved in cell entry [13, 14, 32] . These results demonstrate that T. cruzi strains display major differences in infectivity as well as intracellular growth in macrophages and could favor selection of TcII parasites by host cells.
Incubation of TcII Strains With Chagasic Serum Enhances Uptake by Macrophages
Following infection, acutely generated antibodies anti-T. cruzi could play an important role on the observed parasite selection. Since the studied patients displayed high levels of serum immunoglobulin G (IgG) anti-T. cruzi at the time of diagnosis (data not shown), we investigated whether IgG antibodies influence TcI or TcII selection. Opsonization of IgG antibodies by TcII parasites (SC95 or SC96) enhanced uptake by macrophages. In contrast, no differences were seen in TcI parasites (SC90 or SC91) similarly treated ( Figure 4A ). The enhancement in TcIImacrophage interactions was not observed when either fresh or Figure 2 . TcII populations are selected following passage in macrophages. A, Balb/c mice (n 5 10) were infected intraperitoneally with SC90 plus SC96 (artificially mixed strain), and the proportion of TcI and TcII populations in blood samples at days 7 and 14 and cavity cells at 1 hour and days 3, 7, and 14 was estimated by semiquantitative polymerase chain reaction (PCR) as described in the methods. MW, molecular weight marker (100-bp ladder); 1, TcI control; 2, TcII control; 3, SC90 plus SC96 peritoneal cavity cells at 1 hour after infection; 4, SC90 plus SC96 PECs at day 3 after infection; 5, SC90 plus SC96 PECs at day 7 after infection; 6, SC90 plus SC96 PECs at day 14; 7, SC90 plus SC96 blood at day 7 after infection; 8, SC90 plus SC96 blood at day 14 after infection; 9, negative control (no DNA added). Gel containing PCR products from a representative experiment described above. B, Representative image from PECs isolated from T. cruzi (SC90 plus SC96)-infected animals (day 3 or 7) stained with Giemsa. C, Murine macrophages were infected with SC90 plus SC96 (artificially mixed strain), SC92, or SC93 (naturally mixed strains). After completion of the biological cycle (96-120 h), extracellular parasites were collected and the proportion of TcI and TcII populations was estimated as in A. MW, molecular weight marker (100-bp ladder); 1, TcII control; 2, TcI control; 3-6, SC90 plus SC96; 4-7, SC92; 5-8, SC93; 9, negative control (no DNA added). D, Human macrophages were infected with SC92 strain and subjected to 3 serial passages. After each passage, extracellular parasites were collected and used to assess the proportion of TcI and TcII populations by qPCR. Results are mean 6 SD of measurements from 2 independent experiments performed in triplicate. E, Gel containing PCR products from a representative experiment described in D.
inactivated normal sera were used, suggesting that this process requires antibodies and not complement-associated pathways. Moreover, doubling time was not influenced by IgG opsonization ( Figure 4B ). Together, these results demonstrate that humoral adaptive immune responses may contribute for TcII selection by favoring an enhancement of macrophage entry.
Both TcI and TcII T. cruzi Parasite Growth Are Controlled in IFN-g-Activated Macrophages
Within development of T. cruzi infection and induction of adaptive immune responses, several cytokines are critical to control parasite growth, and IFN-c plays a central role in this effect [19, 20, 33, 34] . Next, we evaluated whether IFN-c differentially inhibits parasite replication in macrophages. No differences were found in the sensitivity of T. cruzi strains to IFN-c in vitro ( Figure 5A ). Moreover, infected macrophages with either TcI or TcII strains display comparable levels of NO ( Figure 5B ), a known intracellular killing pathway involved in controlling T. cruzi replication [19, 34] . These findings suggest that IFN-c/NO-signaling pathways may not be involved in intracellular selection of TcII T. cruzi by murine macrophages.
DISCUSSION
It has been established that the majority of T. cruzi strains isolated from chronic chagasic patients display TcII-associated genetic profiles, whereas in acute infection, TcI, TcII, or mixed TcI/TcII strains may be present [3] [4] [5] [6] [7] [8] [9] [10] [35] [36] [37] . Thus, we hypothesized that TcII populations are selected into the human host. In the present study, using primary physiologic macrophages, we report evidence that TcII strains present higher infective and multiplicative ability as well as a lower doubling time than TcI parasites.
We have previously reported that the strains isolated from humans (SC94-SC102) belong to the TcII group [21] . Consistent with the RAPD analysis observed herein, the 3 major markers (mini-exon, 24Sa rDNA, and 18S rDNA), revealed that these strains cluster into the TcIIb subgroup, also called TcII [7] . These results reinforce the concept that TcII populations are maintained in humans after ingestion of naturally vectorderived TcI/TcII mixed strains. However, we failed to identify TcI parasites among strains isolated from humans as early as 32 d after infection and this could be due to a low sensitivity of the PCR test to detect the low number of TcI parasite DNA. Nevertheless, in agreement with previously published reports [3] [4] [5] [6] [7] [8] [9] [10] [35] [36] [37] , the present study confirms that TcII strains are the majority of parasites in patients with Chagas disease.
Consistent with these results, we have observed that mice infected with mixed TcI/TcII strains (SC90 plus SC96) display circulating parasites with TcII-associated genetic profiles during experimental T. cruzi infection in vivo. Additionally, in vitro assays using primary human or murine macrophages infected with vector-derived mixed TcI/TcII strains have shown increased detection of TcII DNA as opposed to decreased measurement of TcI strains. These findings may help to explain why the majority of strains from chronic chagasic patients belong to the TcII group [3] [4] [5] [6] [7] [8] [9] [10] [35] [36] [37] . Moreover, our results establish an in vivo model in which observations previously reported in infected patients have also been found in mice. Nevertheless, further studies using such animal models may be undertaken to understand the roles of host and parasite molecules in the in vivo TcII selection process.
Our data support the idea that macrophages, the major phagocyte population implicated in T. cruzi uptake and/or Figure 4 . Sera from chagasic patients enhance TcII but not TcI strains' uptake by macrophages. A, SC95, SC96 (TcII), SC90, and SC91 (TcI) strains' trypomastigotes forms were preincubated for 1 hour at 37°C with normal serum (NS), inactivated normal serum (NSI), or inactivated chagasic serum (CSI). Macrophages were then infected for 4 hours and the average number of amastigotes was determined in 200 randomly Giemsa-stained cells. Control group C consisted of the parasites without preincubation with serum. B, Opsonization of Trypanosoma cruzi strains with chagasic serum does not influence doubling time of parasites in macrophages. The doubling time was assessed as described in the Methods. Results are mean 6 SD of measurements from 2 independent experiments performed in triplicate. An asterisk (*) indicates a statistically significant difference (P ,.05) in infection rates between macrophages infected with TcI vs TcII strains. invasion [17, 18, 38] , are involved in TcII parasite selective processes in vivo (Figure 2) . By employing T. cruzi-macrophage interaction experiments, we have observed major differences in the biological behavior of TcI vs TcII strains. The infective and multiplicative ability of TcII strains (SC95 and SC96) were found to be higher than that of TcI strains (SC90 and SC91), suggesting that selection of TcII populations in vivo may be related to the biological characteristics of the parasite. Invasion, phagocytosis, and intracellular signaling pathways are examples of key molecular hubs regulated by T. cruzi to establish a survival niche in the human host [39] . It is possible that these pathways are differentially regulated by TcI vs TcII strains.
We found that the observed lower infectivity of TcI trypomastigote strains was associated with a slightly decreased expression of gp82, which has been shown to be involved in T. cruzi infection at the cellular level [13, 32] . Extensive studies with metacyclic forms of several T. cruzi strains have revealed 2 groups of parasites that differentially express surface glycoproteins and display differential ability to invade mammalian cells in vitro [13, 14, 32] . Trypomastigotes of highly invasive CL isolate express gp82 [13, 32] , which efficiently triggers Ca 21 signaling in parasites and host cells [14] , whereas poorly invasive G strain parasites appear to rely mainly on gp35/50 for their internalization [29] . Our data suggest that it may be possible that membrane expression of invasion proteins, in addition to gp82, could account for differences in infectivity by TcI vs TcII strains. This finding merits further investigation.
During T. cruzi infection, circulating antibodies may be involved in regulating the process of parasite-host cell interactions. As reported here, opsonization of TcII parasites using sera from chagasic patients enhanced their uptake by macrophages, while no differences were observed in TcI strains, reinforcing that cell infection and intracellular multiplication is T. cruzi group-dependent. In addition, it is possible that anti-T. cruzi high-affinity antibodies produced during infection contribute to enhancement of TcII uptake in vivo. Consistent with this, TcII protein extracts appear to be more antigenic than similar TcI preparations when acute or chronic chagasic patient sera were used (data not shown). Whether TcII, but not TcI, benefits from humoral responses to hijack macrophage-killing pathways has yet to be determined.
Control of T. cruzi parasitism during infection is considered to be critically dependent on effective macrophage activation by cytokines. IFN-c plays a major role on intracellular killing of amastigotes by macrophages [16-20, 40, 41] , and IFNc-activated cells control T. cruzi replication by triggering production of reactive oxygen and nitrogen metabolites, including NO [19, 20, 40, 41] . It has been largely demonstrated that specific inhibitors of inducible NO synthase, both in vitro [19] and in vivo [42] , inhibit the trypanocidal activity of murine macrophages. In the present study, we found that IFN-c-activated macrophages are able to control the parasite proliferation through an NOS2-dependent pathway, regardless of the strain. It is still possible that other IFN-c-activated pathways such as GTPase-mediated mechanisms [43] or IFNc-independent pathways may regulate TcII selection by macrophages. We observed that interleukin 10, a known cytokine involved in T. cruzi infection [19, 44] , was not differentially regulated by TcI-vs TcII-infected macrophages (data not shown). Current studies are under way to explore possible macrophage host molecules influencing parasite selection.
In summary, our findings suggest that biological characteristics of the parasite, such as infective and multiplicative ability, may favor selection of TcII parasites and contribute to the pathogenesis of Chagas disease. These results may help to understand T. cruzi heterogeneity and host cell interactions and could be useful in developing novel therapeutic and preventive strategies. 
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